Mass drug administration for malaria elimination: do we understand the settings well enough?
BMC Med
; 16(1): 239, 2018 12 19.
Article
en En
| MEDLINE
| ID: mdl-30563509
ABSTRACT
Mass drug administration (MDA) of antimalarials has re-emerged as a recommended tool for interrupting malaria transmission, but evidence from low endemicity settings is scarce. A trial in Zanzibar found that two rounds of MDA made no significant impact on malaria incidence, and many questions on the optimal mode and setting for implementing MDA remain unanswered. A more thorough understanding of local sources and drivers of transmission, and a better toolbox for evaluating interventions in near-elimination settings are essential.Please see related research article https//bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1202-8 .
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Malaria
Tipo de estudio:
Incidence_studies
/
Prognostic_studies
Límite:
Humans
País/Región como asunto:
Africa
Idioma:
En
Revista:
BMC Med
Asunto de la revista:
MEDICINA
Año:
2018
Tipo del documento:
Article
País de afiliación:
Suiza